NeuroSense Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NeuroSense Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-12-18 | $-0.11 | $-0.16 | 31.3 % |
Jun 2024 | 2024-09-30 | $-0.02 | $-0.20 | 90.0 % |
Mar 2024 | 2024-06-24 | $-0.35 | $-0.20 | -75.0 % |
Mar 2024 | 2024-04-05 | $-0.16 | $-0.23 | 30.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
NeuroSense Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on December 18, 2024 for Q3.
NeuroSense Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on December 18, 2024 for Q3 and the Actual EPS was $-0.11, which beat the estimate of $-0.16.
NeuroSense Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on December 18, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.